Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03306524
Other study ID # 16/28
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2017
Est. completion date June 30, 2018

Study information

Verified date May 2019
Source Cambridge University Hospitals NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During neonatal mechanical ventilation inflating pressures, tidal volumes, and inflation and expiration times need to be set and adjusted to optimise oxygenation and carbon dioxide removal. The flow of gas into the ventilator circuit has a big effect on ventilation but is usually set to a constant value (~8 L/min) for all babies regardless of size or severity of illness, based on minimal research. High circuit flow may lead to lung damage and low flow to inadequate ventilation. The investigators recently developed a unique system to capture, record, analyse, and display ventilator data at high resolution over long periods. Using this the investigators will investigate, in within patient cross-over studies, how the level of gas flow affects ventilator parameters and ventilation, in two commonly used ventilation modes. The results will determine the lowest circuit flow that ventilates a baby safely and effectively. It will also provide preliminary data for a randomised trial.


Description:

- Background of the project

About 1.5% of newborns require mechanical ventilation. Although mechanical ventilation can be life-saving for neonates with respiratory failure, it may cause lung injury due to excess airway pressure (barotrauma), delivery of high tidal volumes (volutrauma) and repetitive closing/re-opening of lung units (atelectotrauma)1. Very preterm neonates are especially vulnerable to ventilator induced lung injury. Ventilator associated lung injury is one of several factors contributing to the burden of chronic lung disease of infancy, also called bronchopulmonary dysplasia (BPD).

Ventilators have several different modes. The most frequently used mode is, time-cycled, pressure limited, where the doctor sets inspired oxygen level, the peak inflation pressure (PIP), rate, and inflation time of the ventilator. In this mode the inflations are usually synchronised with the baby's breathing. This is either Synchronised Intermittent Positive Pressure Ventilation (SIPPV), where the ventilator synchronises inflations with all the baby's breaths, or Synchronised Intermittent Mandatory Ventilation (SIMV), where the ventilator only synchronises with a set number of breaths. These can be delivered with or without targeting the tidal volume delivered to a set value by adjusting the peak inflating pressure. This mode is called volume guarantee (VG). A similar mode of ventilation is flow-cycled or Pressure Support Ventilation (PSV) and can be combined with tidal volume targeting 2. In this mode the inflation is terminated as soon as the flow rate falls to 15% of the maximum flow during inflation.

These modes have continuous gas flow through the ventilation circuit. Inflation starts and pressure rises when the expiratory valve is closed. The rate of circuit flow alters the ventilation waveforms. With time-cycled ventilation the higher the circuit flow the faster the pressure rises, the lung is distended and potentially injured, and the earlier the set PIP is achieved. A high flow, with a relatively long inflation time will result in a "pressure plateau", that is the PIP is sustained after the flow, into the baby, has stopped because the lung volume is maximal at the PIP used (Figure 1). In PSV inflation stops when the flow has decreased to ~15% of the peak inflation flow and so the inflation time is shorter. Increasing the device flow shortens the inflation time and thereby reduces the mean airway pressure.

Despite the effects on ventilation patterns and the speed of lung distension and injury, consideration has rarely been given to the circuit flow. By protocol, it is usually set at 7-10 L/min when the ventilator is turned on and it is not changed.

This is relatively high, and usually produces a "square" pressure waveform with a rapid distention of the lungs and a sustained pressure plateau. (see A in figure 1) With PSV a high flow results in a relatively short inflation time (~0.2 sec; it needs to be at least 0.3 sec for adequate lung aeration). There is no evidence these high flows are best for optimum ventilation and minimum lung damage. In a preterm lamb model there were no adverse effects on gas exchange or cardiovascular parameters until the flow was reduced to 3 l/min 3. In animal studies ventilation with high flow resulted in histologic and molecular changes of lung injury 4. The effect of lowering the ventilator circuit flow rate has never been investigated in clinical studies.

The Dräger Babylog VN500 ventilator has an alternative to setting a gas flow: the user can set the slope time instead, that is time required to reach the set pressure. In Cambridge it is invariably set to 0.08 sec which results in a flow ~7 L/min. As we use an inflation time between 0.33 - 0.45 sec, there is a pressure plateau lasting at least 0.25 sec and sustained inflation with little or no flow.

The investigators are the first to develop a unique system for downloading and analysing data from the Dräger VN500 neonatal ventilator. Using DataGrabber software obtained from Dräger Medical, the investigators can retrieve ventilator parameters at 100Hz frequency over long periods (hours and even days). To analyse and visualise the large datasets the investigators developed a data analysis workflow using the Python programing language and its add-on packages (Figure 2). With this tool the investigators can now study details of each inflation and spontaneous breath. The Investigators have recorded detailed data from 30 babies and shown it is feasible, accurate, and the investigators have the expertise (Belteki et al, submitted).

In this application the investigators propose to investigate the effect of different slope times (and therefore different levels of circuit flow) on ventilation parameters and gas exchange in preterm infants. The investigators hypothesise that a longer slope time (= lower circuit flow) will distend the lungs more gently yet maintain ventilation and gas exchange.

- Intervention:

The study is a within patient crossover design comparing short periods of ventilation with different slope times both in SIPPV-VG and PSV-VG modes with the following interventions:

A ventilator download tool and transcutaneous and expired CO2 monitors is attached to the ventilator and data download commences while the baby is ventilated with the parameters used by the clinical team. An arterial blood gas is performed. The ventilated parameters are changed as shown below. The order of these epochs is randomised. Another arterial blood gas is performed. Ventilator is changed back to the original parameters (or different as appropriate by the blood gas). Ventilator data and CO2 recording will be continued for another 30 minutes.

Interventions

Duration Ventilator More Slope time Inspiratory time[max] 15 min SIPPV-VG 0.08 0.40 15 min PSV-VG 0.08 [0.60] 15 min PSV-VG 0.16 [0.60] 15 min SIPPV-VG 0.16 0.40 15 min SIPPV-VG 0.24 0.40 15 min PSV-VG 0.24 [0.60] 15 min PSV-VG 0.32 [0.60] 15 min SIPPV-VG 0.32 0.40 15 min SIPPV-VG 0.40 0.40 115 min PSV-VG 0.40 [0.60]

Total study duration is 220 minutes. A researcher will be present continuously. FiO2 will be adjusted if needed to maintain saturations between 90-95%. If the FiO2 rises >15% or the end-tidal CO2 rises >1.5kPa over the pre-study level, that intervention will be abandoned.

Comparison:

At each slope time, the following parameters will be determined and compared with those recorded at 0.08 sec slope time: (1) peak inflating pressure, (2) inflation duration, (3) duration of inflation plateau, (4) duration of no gas flow, (5) expired tidal and minute volumes (mandatory/spontaneous, inspiratory/expiratory, (6) ventilator rate, (7) FiO2, (8) transcutaneous and/or end-tidal CO2 and, (9) interaction between ventilator inflations and baby's breaths. Values for SIPPV and PSV will also be compared.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date June 30, 2018
Est. primary completion date June 30, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Months
Eligibility Inclusion Criteria:

- Birth weight < 2 kg;

- Ventilated with SIPPV-VG modes,

- Informed parental consent,

- Clinician assent.

Exclusion Criteria:

- Baby's respiratory condition unstable (Inspired oxygen (FiO2) > 50%, PaCO2 > 8.5kPa or <5kPa in the last 12 hours)

- Extubation planned in the next 12 hours;

- Neonatal or surgical procedure in the last 12 hours or planned in the next 12 hours;

- Significant pneumothorax requiring drainage;

- Gas leak around the endotracheal tube >50%; #

- No arterial access;

- The responsible clinician does not agree with recruitment;

- Parents do not consent.

Study Design


Related Conditions & MeSH terms

  • Respiratory Distress Syndrome in Premature Infant
  • Respiratory Distress Syndrome, Adult
  • Respiratory Distress Syndrome, Newborn

Intervention

Device:
SIPPV_VG_0_08
Mechanical ventilation using SIPPV-VG ventilator mode with a slope time of 0.08 seconds, inspiratory time of 0.40 seconds for 15 minutes
SIPPV_VG_0_16
Mechanical ventilation using SIPPV-VG ventilator mode with a slope time of 0.16seconds, inspiratory time of 0.40 seconds for 15 minutes
SIPPV_VG_0_24
Mechanical ventilation using SIPPV-VG ventilator mode with a slope time of 0.24 seconds, inspiratory time of 0.40 seconds for 15 minutes
SIPPV_VG_0_32
Mechanical ventilation using SIPPV-VG ventilator mode with a slope time of 0.32 seconds, inspiratory time of 0.40 seconds for 15 minutes
SIPPV_VG_0_40
Mechanical ventilation using SIPPV-VG ventilator mode with a slope time of 0.40 seconds, inspiratory time of 0.40 seconds for 15 minutes
PSV_VG_0_08
Mechanical ventilation using PSV-VG ventilator mode with a slope time of 0.08 seconds, maximum inspiratory time of 0.60 seconds for 15 minutes
PSV_VG_0_16
Mechanical ventilation using PSV-VG ventilator mode with a slope time of 0.16 seconds, maximum inspiratory time of 0.60 seconds for 15 minutes
PSV_VG_0_24
Mechanical ventilation using PSV-VG ventilator mode with a slope time of 0.24 seconds, maximum inspiratory time of 0.60 seconds for 15 minutes
PSV_VG_0_32
Mechanical ventilation using PSV-VG ventilator mode with a slope time of 0.32 seconds, maximum inspiratory time of 0.60 seconds for 15 minutes
PSV_VG_0_40
Mechanical ventilation using PSV-VG ventilator mode with a slope time of 0.40 seconds, maximum inspiratory time of 0.60 seconds for 15 minutes

Locations

Country Name City State
United Kingdom Neonatal Intensive Care Unit, Cambridge University Hospitals NHS Trust Cambridge

Sponsors (1)

Lead Sponsor Collaborator
Cambridge University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (4)

Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002 Oct;7(5):353-60. Review. — View Citation

Bach KP, Kuschel CA, Hooper SB, Bertram J, McKnight S, Peachey SE, Zahra VA, Flecknoe SJ, Oliver MH, Wallace MJ, Bloomfield FH. High bias gas flows increase lung injury in the ventilated preterm lamb. PLoS One. 2012;7(10):e47044. doi: 10.1371/journal.pone.0047044. Epub 2012 Oct 8. — View Citation

Bach KP, Kuschel CA, Oliver MH, Bloomfield FH. Ventilator gas flow rates affect inspiratory time and ventilator efficiency index in term lambs. Neonatology. 2009;96(4):259-64. doi: 10.1159/000220765. Epub 2009 May 27. — View Citation

Nafday SM, Green RS, Lin J, Brion LP, Ochshorn I, Holzman IR. Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study. J Perinatol. 2005 Mar;25(3):193-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary End tidal CO2 measurement Primary outcome will be the difference in end-tidal CO2 concentration during the epochs with slope times of 0.40 and 0.08 sec. One year
See also
  Status Clinical Trial Phase
Recruiting NCT04016246 - Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation. Phase 3
Enrolling by invitation NCT04118400 - Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates
Completed NCT01941745 - Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome Phase 2
Not yet recruiting NCT04019106 - Budesonide With Intratracheal Surfactants in Extremely Preterm Infants Phase 1/Phase 2
Not yet recruiting NCT04862377 - Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. Phase 3
Not yet recruiting NCT05791331 - REspiratory MEchanics for Delivering Individualised Exogenous Surfactant N/A
Completed NCT04086095 - Feasibility Study - Neofact N/A
Not yet recruiting NCT05609877 - The NONA-LISA Trial N/A
Recruiting NCT04326270 - Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs N/A
Active, not recruiting NCT03969992 - A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact Phase 2
Completed NCT03700606 - Physiological Changes With High-Flow Nasal Cannula N/A
Recruiting NCT04359134 - Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.
Not yet recruiting NCT06229821 - Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants N/A
Recruiting NCT05446389 - PAL to Improve Oral Feeding for Infants With Chronic Lung Disease N/A
Withdrawn NCT04914715 - nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome N/A
Recruiting NCT03825835 - 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants N/A
Recruiting NCT03562182 - Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA
Completed NCT05031650 - Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room N/A
Completed NCT01473264 - Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS) Phase 1/Phase 2
Completed NCT03548324 - Enteral Nutrition Tolerance And REspiratory Support (ENTARES) N/A